اخبار و اعلانات

 آمار

تعداد نشریات285
تعداد نشریات سازمان83
تعداد شماره‌ها3,086
تعداد مقالات34,441
تعداد مشاهده مقاله48,897,673
تعداد دریافت فایل اصل مقاله79,343,452
Shamkhi, G. J, Alkhuzai, R. A. H, Al-Shukr, N. M. K. (1401). Molecular Genotyping of Chlamydia trachomatis in Iraqi Married Pregnant and Non-Pregnant Women. سامانه مدیریت نشریات علمی, 77(2), 761-769. doi: 10.22092/ari.2022.357121.1978
G. J Shamkhi; R. A. H Alkhuzai; N. M. K Al-Shukr. "Molecular Genotyping of Chlamydia trachomatis in Iraqi Married Pregnant and Non-Pregnant Women". سامانه مدیریت نشریات علمی, 77, 2, 1401, 761-769. doi: 10.22092/ari.2022.357121.1978
Shamkhi, G. J, Alkhuzai, R. A. H, Al-Shukr, N. M. K. (1401). 'Molecular Genotyping of Chlamydia trachomatis in Iraqi Married Pregnant and Non-Pregnant Women', سامانه مدیریت نشریات علمی, 77(2), pp. 761-769. doi: 10.22092/ari.2022.357121.1978
Shamkhi, G. J, Alkhuzai, R. A. H, Al-Shukr, N. M. K. Molecular Genotyping of Chlamydia trachomatis in Iraqi Married Pregnant and Non-Pregnant Women. سامانه مدیریت نشریات علمی, 1401; 77(2): 761-769. doi: 10.22092/ari.2022.357121.1978

Molecular Genotyping of Chlamydia trachomatis in Iraqi Married Pregnant and Non-Pregnant Women

Archives of Razi Institute
مقاله 33، دوره 77، شماره 2، خرداد و تیر 2022، صفحه 761-769    اصل مقاله (524.22 K)
نوع مقاله: Original Articles
شناسه دیجیتال (DOI): 10.22092/ari.2022.357121.1978
نویسندگان
G. J Shamkhi* 1؛ R. A. H Alkhuzai2، 3؛ N. M. K Al-Shukr2
1Department of Biology, College of Science, University of Wasit, Wasit, Iraq
2Department of Medical Laboratory Technique, the Islamic University, Diwaniya, Iraq
3Department of Research and Studies, the Islamic University, Najaf, Iraq
چکیده
It has been approved that the infection caused by Chlamydia trachomatis (C. trachomatis) is one of the major causes of infertility and adverse birth outcomes in populations. The C. trachomatis epidemiology among childbearing-age women in Iraq has not been recognized yet. This study aimed to detect the prevalence of C. trachomatis infection among pregnant and non-pregnant women using the polymerase chain reaction (PCR) assay and phylogenetic analysis of local isolates. In total, 200 endocervical swabs were collected from adult married pregnant (n=100) and non-pregnant women (n=100) from June to July 2021. Targeting the omp1 gene, 9% of the total samples were positive for C. trachomatis, and significant increases were reported among non-pregnant compared to pregnant women. The PCR products of five positive local isolates were selected randomly, sequenced, and documented in the National Centre for Biotechnology Information (NCBI) with the accession numbers OK094104.1, OK094105.1, OK094106.1, OK094107.1, and OK094108.1. Analysis of the homology sequence of the local and NCBI-BLAST isolates revealed a significant association with the Russian (MF288585.1) isolate. Statistical analysis of reproductive data revealed a higher prevalence, odds ratio (OD), and risk in asymptomatic, compared to symptomatic cases. Although no significant variation was detected in prevalence rate among single and multiple symptomatic women, increases were observed in OD values and risk of multiple symptomatic women. Reportedly, chronic pelvic pain was more prevalent than pelvic inflammatory diseases, ectopic pregnancy, and infertility in single symptomatic women. Regarding the demographic characteristics (i.e., age, the place of residence, and occupation), prevalence and risk of infection were higher in women who were <30 years, lived in urban areas, and had a job, compared to women who were ≥30 years, lived in suburban and rural areas, and had a free job. In conclusion, the course of chlamydial infections is usually unpredictable, diverse, and asymptomatic and has remained almost unrecognized. Therefore, PCR-based methods can apply successfully to detect C. trachomatis in both pregnant and non-pregnant women.
کلیدواژه‌ها
Chlamydiasis؛ Demographic factor؛ Iraq؛ Phylogenetic analysis؛ Polymerase chain reaction؛ Reproductive data
سایر فایل های مرتبط با مقاله
مراجع
  1. Byrne GI. Chlamydia trachomatis strains and virulence: rethinking links to infection prevalence and disease severity. J Infect Dis. 2010;201(2):126-33.
  2. Rawre J, Juyal D, Dhawan B. Molecular typing of Chlamydia trachomatis: An overview. Indian J Med Microbiol. 2017;35(1):17-26.
  3. Witkin SS, Minis E, Athanasiou A, Leizer J, Linhares IM. Chlamydia trachomatis: the persistent pathogen. Clin Vaccine Immunol. 2017;24(10):00203-17.
  4. Dhawan B, Rawre J, Ghosh A, Malhotra N, Ahmed MM, Sreenivas V, et al. Diagnostic efficacy of a real time-PCR assay for Chlamydia trachomatis infection in infertile women in north India. Indian J Med Res. 2014;140(2):252.
  5. Mohan D, Borthakur A. Seroprevalence of Chlamydia trachomatis in infertile women in a tertiary care hospital: a pilot study. Indian J Med Microbiol. 2015;33(2):331.
  6. Rekart ML, Gilbert M, Meza R, Kim PH, Chang M, Money DM, et al. Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy. J Infect Dis. 2013;207(1):30-8.
  7. Stary A, Stary G. Chlamydia trachomatis: diagnostic procedures. Sexually Transmitted Infections and Sexually Transmitted Diseases: Springer; 2011. p. 111-9.
  8. Cicinelli E, De Ziegler D, Nicoletti R, Tinelli R, Saliani N, Resta L, et al. Poor reliability of vaginal and endocervical cultures for evaluating microbiology of endometrial cavity in women with chronic endometritis. Gynecol Obstet Invest. 2009;68(2):108-15.
  9. Bandea CI, Jerris RC, Black CM. Chlamydia. Manual of Commercial Methods in Clinical Microbiology: International Edition. 2016:175-83.
  10. Meyer T. Diagnostic procedures to detect Chlamydia trachomatis infections. Microorganisms. 2016;4(3):25.
  11. Borborema-Alfaia APBd, Freitas NSdL, Astolfi Filho S, Borborema-Santos CM. Chlamydia trachomatis infection in a sample of northern Brazilian pregnant women: prevalence and prenatal importance. Braz J Infect Dis. 2013;17:545-50.
  12. Abdulrahman MT, Jassim HA, Alsharef M. Serological Detection of Chlamydia trachomatis among Infertile Women in Basra. Int J Sci Eng Res. 2016;7(3):1229-33.
  13. Sahi AA, Mohammed KA. Comparison of immunological and molecular methods for the detection of Chlamydia trachomatis among infertile women in Basra, Iraq. Ann Trop Med Public Health. 2020;23:232-7.
  14. Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PloS One. 2015;10(12):e0143304.
  15. Özdamar M, Sözen İ, sağlam FY, Güçer F, Donat EF, Türkoğlu S. Chlamydia trachomatis screening by polymerase chain reaction among asymptomatic turkish women: a prevalence study. Acta Medica. 2016;32:1009.
  16. Ali MK, Shia JS. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in genitourinary specimens in Iraq women by real time PCR assay. Res J Pharm Biol Chem Sci. 2018;9(6):799-808.
  17. El Qouqa IA, Shubair ME, Al Jarousha AM, Sharif FA. Prevalence of Chlamydia trachomatis among women attending gynecology and infertility clinics in Gaza, Palestine. Int J Infect Dis. 2009;13(3):334-41.
  18. Rashidi BH, Tabriz LC, Haghollahi F, Ramezanzadeh F, Shariat M, Foroushani AR, et al. Prevalence of Chlamydia trachomatis infection in fertile and infertile women; a molecular and serological study. J Reprod Infertil. 2009;10(1).
  19. Marcone V, Recine N, Gallinelli C, Nicosia R, Lichtner M, Degener A, et al. Epidemiology of Chlamydia trachomatis endocervical infection in a previously unscreened population in Rome, Italy, 2000 to 2009. Eurosurveillance. 2012;17(25):20203.
  20. Mehrabani D, Behzadi MA, Azizi S, Payombarnia H, Vahdani A, Namayandeh M, et al. Cervical infection with Herpes simplex virus, Chlamydia trachomatis, and Neisseria gonorrhoeae among symptomatic women, Dubai, UAE: a molecular approach. Interdiscip Perspect Infect Dis. 2014;2014.
  21. Tosun I, Cihanyurdu M, Kaklikkaya N, Topbas M, Aydin F, Erturk M. Asymptomatic Chlamydia trachomatis infection and predictive criteria among low-risk women in a primary care setting. Jpn J Infect Dis. 2008;61(3):216.
  22. Vahidnia A, den Buijs IO, Roymans R, Bliekendaal H, van de Bovenkamp J. A retrospective study into the prevalence of herpes simplex virus 1&2 in female patients tested for Chlamydia trachomatis and/or Neisseria gonorrhoeae using vaginal swabs. Clin Microbiol Infect. 2013;19(3):166-8.
  23. Gottlieb SL, Martin DH, Xu F, Byrne GI, Brunham RC. Summary: The natural history and immunobiology of Chlamydia trachomatis genital infection and implications for Chlamydia control. J Infect Dis. 2010;201(2):190-204.
  24. Workowski KA. Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis. 2015;61(8): 759-62.
  25. Bianchi S, Frati E, Canuti M, Colzani D, Fasoli E, Amendola A, et al. Molecular epidemiology and genotyping of Chlamydia trachomatis infection in a cohort of young asymptomatic sexually active women (18-25 years) in Milan, Italy. J Prev Med Hyg. 2016;57(3):128.
  26. Torrone E, Papp J, Weinstock H. Prevalence of Chlamydia trachomatis genital infection among persons aged 14–39 years—United States, 2007–2012. MMWR Morb Mortal Wkly Rep. 2014;63(38):834.
  27. Detels R, Green AM, Klausner JD, Katzenstein D, Gaydos C, Handsfield HH, et al. The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries. Sex Transm Dis. 2011;38(6):503.
  28. Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection). Trial BMJ. 2010;340.
  29. Zimmerman HL, Potterat JJ, Dukes RL, Muth JB, Zimmerman HP, Fogle JS, et al. Epidemiologic differences between chlamydia and gonorrhea. Am J Public Health. 1990;80(11):1338-42.
  30. Morré SA, Van Den Brule AJ, Rozendaal L, Boeke AJP, Voorhorst FJ, De Blok S, et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up. Int J STD AIDS. 2002;13(1):12-8.
  31. Burton MJ, Bowman R, Faal H, Aryee E, Ikumapayi U, Alexander N, et al. Long term outcome of trichiasis surgery in the Gambia. Br J Ophthalmol. 2005;89(5):575-9.
  32. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis. 2010;201(2):134-55.
  33. Bachmann LH, Richey CM, Waites K, Schwebke JR, Hook III EW. Patterns of Chlamydia trachomatis Testing and Follow-Up at a University Hospital Medical Center. Sex Transm Dis. 1999;26(9):496-9.
  34. Zarb P, Coignard B, Griskeviciene J, Muller A, Vankerckhoven V, Weist K, et al. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Eurosurveillance. 2012;17(46):20316.
  35. Rabiah MG, Mutahar R, Sitorus RJ, editors. The Risk Factors Analysis Occurrence of Chlamydia Infection to Direct Female Seks Workers (DFSW) in Indonesia. E3S Web of Conferences; 2018: EDP Sciences.
  36. O’Connell CM, Ferone ME. Chlamydia trachomatis genital infections. Microbial cell. 2016;3(9):390.
  37. Bailey R, Duong T, Carpenter R, Whittle H, Mabey D. The duration of human ocular Chlamydia trachomatis infection is age dependent. Epidemiol Infect. 1999;123(3):479-86.
  38. McCormack WM, Alpert S, McComb DE, Nichols RL, Semine DZ, Zinner SH. Fifteen-month follow-up study of women infected with Chlamydia trachomatis. N Engl J Med. 1979;300(3):123-5.
  39. Geisler WM. Diagnosis and management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: summary of evidence reviewed for the 2010 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis. 2011;53(3):92-8.
  40. Low N, McCarthy A, Macleod J, Salisbury C, Campbell R, Roberts T, et al. Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Health technology assessment (Winchester, England). 2007;11(8).
  41. Paukku M, Kilpikari R, Puolakkainen M, Oksanen H, Apter D, Paavonen J. Criteria for selective screening for Chlamydia trachomatis. Sex Transm Dis. 2003;30(2):120-3.
  42. West J, Lawlor DA, Santorelli G, Collings P, Whincup PH, Sattar NA, et al. Associations of social and economic and pregnancy exposures with blood pressure in UK White British and Pakistani children age 4/5. Sci Rep. 2018;8(1):1-10.
  43. Neiderud C-J. How urbanization affects the epidemiology of emerging infectious diseases. Infect Ecol Epidemiol. 2015;5(1):27060.
  1. Patterson-Lomba O, Goldstein E, Gómez-Liévano A, Castillo-Chavez C, Towers S. Per capita incidence of sexually transmitted infections increases systematically with urban population size: a cross-sectional study. Sex Transm infect. 2015;91(8):610-4.
  2. Belay T, Woart A. Cold-induced stress increases the intensity of Chlamydia genital infection in mice. J Microbiol Immunol Infect. 2013;46(5):330-7.
  3. Sun G, Pal S, Sarcon AK, Kim S, Sugawara E, Nikaido H, et al. Structural and functional analyses of the major outer membrane protein of Chlamydia trachomatis. J Bacteriol. 2007;189(17):6222-35.
  4. Feodorova V, Sultanakhmedov E, Saltykov Y, Zaitsev S, Utz S, Corbel M, et al. First detection of chlamydia trachomatis' Swedish'variant (nvCT) in a Russian couple with infertility. Open Microbiol J. 2018;12:343.
آمار
تعداد مشاهده مقاله: 2,226
تعداد دریافت فایل اصل مقاله: 2,861


counter
سامانه مدیریت نشریات علمی. طراحی و پیاده سازی از سیناوب